One of the biggest challenges in clinical research is poor compliance. Subjects who dropout, and who therefore do not provide data specific to study endpoints, are wasted money. A high dropout rate requires a larger sample size, leading to longer recruitment timelines and a surge in study costs.
We’re in the midst of a technology transformation in healthcare. Robots are performing surgery, visits to the doctor occur online, and medical devices are smarter than ever. Research studies are no different.
Digital technology can now enable collecting data from participants in their homes, during their everyday lives, instead of inconvenient, costly trips to the clinic. It’s as simple as having a smart phone.
Lack of diversity within the clinical trial industry poses a grave problem. We cannot assume medicines work similarly across ethnicities.
Writing claims conforming to The Dietary Supplement Health and Education Act of 1994 ("DSHEA"), can be both challenging and frustrating. It’s a classic clash of needs versus wants.
What’s needed to write an acceptable claim, may not always match the evidence you want to use. For nutraceuticals producers, what you can claim—and just importantly, what competitors don’t—impacts demand for your products.